Fiji vs Tunisia: Access to anti-retroviral drugs, male
Fiji
28.0%
in 2024
Tunisia
28.0%
in 2024
Fiji rank
133rd
Tunisia rank
133rd
Access to anti-retroviral drugs, male over time
- Fiji
- Tunisia
How they compare
Fiji currently reports 28.0% against 28.0% in Tunisia, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Tunisia ahead.
Fiji ranks 133rd and Tunisia ranks 133rd of 141 countries.
Across the 3 decades both report, Fiji averaged higher in 2 and Tunisia in 1.
Head to head by decade
| Decade | Fiji | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 41.2% | 3.7% | 37.5% | Fiji |
| 2010s | 33.5% | 10.5% | 23.0% | Fiji |
| 2020s | 19.6% | 22.0% | 2.4% | Tunisia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Fiji or Tunisia?
- Fiji, at 28.0% against 28.0% in Tunisia as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Fiji and Tunisia?
- 0.0%, with Fiji ahead.
- How many years of comparable data are there for Fiji and Tunisia?
- 25 years are reported by both, from 2000 to 2024.
- How do Fiji and Tunisia rank globally for access to anti-retroviral drugs, male?
- Fiji ranks 133rd and Tunisia ranks 133rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.